.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Covington
Baxter
Medtronic
Cantor Fitzgerald
Johnson and Johnson
Chubb
Colorcon
McKinsey
Healthtrust

Generated: June 24, 2017

DrugPatentWatch Database Preview

NULYTELY Drug Profile

« Back to Dashboard

What is the patent landscape for Nulytely, and when can generic versions of Nulytely launch?

Nulytely is a drug marketed by Braintree and is included in one NDA.

The generic ingredient in NULYTELY is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are four hundred and seventeen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.

Summary for Tradename: NULYTELY

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list63
Clinical Trials: see list8
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NULYTELY at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree
NULYTELY
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
FOR SOLUTION;ORAL019797-001Apr 22, 1991AARXYesYes► Subscribe► Subscribe
Braintree
NULYTELY-FLAVORED
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
FOR SOLUTION;ORAL019797-002Nov 18, 1994AARXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
US Army
Julphar
Citi
QuintilesIMS
Deloitte
Colorcon
Novartis
Accenture
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot